Mankind Pharma Limited (BOM:543904)
2,195.65
+52.05 (2.43%)
At close: Apr 21, 2026
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 908.22 billion as of April 22, 2026. Its market cap has decreased by -10.23% in one year.
Market Cap
908.22B
Enterprise Value
959.35B
Revenue
139.14B
Ranking
n/a
PE Ratio
51.04
Stock Price
2,195.65
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 908.22B, an increase of 59.41%. That is a compound annual growth rate of 17.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 908.22B | 0.16% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.41T |
| Lupin | 1.06T |
| Dr. Reddy's Laboratories | 1.03T |
| Abbott India | 548.17B |
| GlaxoSmithKline Pharmaceuticals | 415.35B |
| J. B. Chemicals & Pharmaceuticals | 320.69B |
| AstraZeneca Pharma India | 212.72B |
| Granules India | 162.16B |